Supplementary Materialscancers-10-00527-s001. patients with brain metastases (two CTC HR: 4.694, = 0.004, CI: 1.650C13.354, and five CTC HR: 4.963, = 0.003, CI: 1.752C14.061). Also, oligo-brain NSCLC metastatic patients with CTCs had a very poor prognosis (= 0.019). order SRT1720 Similarly, in other tumor entities, only 9.6% of patients with brain metastases (= 52) had detectable… Continue reading Supplementary Materialscancers-10-00527-s001. patients with brain metastases (two CTC HR: 4.694, =